Description

Pancreatin 8000 (pancreatin) coated tablets 0.24 g. №50

Ingredients

Each coated tablet contains 0.24 g of pancreatin. Other ingredients include cellulose, povidone, talc, and magnesium stearate.

Dosage

The recommended dosage is determined by the healthcare provider based on individual needs. Typically, it is advised to take one tablet with meals or as directed.

Indications

Pancreatin 8000 tablets are indicated for pancreatic enzyme replacement therapy in conditions where pancreatic function is deficient. This includes chronic pancreatitis, cystic fibrosis, and post-pancreatectomy.

Contraindications

Do not use if allergic to any of the ingredients. Consult a healthcare professional before use if pregnant, nursing, or taking other medications.

Directions

Swallow the tablet whole with water, do not crush or chew. Follow the dosage instructions provided by your healthcare provider.

Scientific Evidence

Pancreatin, a mixture of digestive enzymes, has been extensively studied for its efficacy in aiding digestion in individuals with pancreatic insufficiency. Research published in the “Journal of Clinical Gastroenterology” has shown that pancreatin supplementation significantly improves fat absorption and reduces steatorrhea in patients with chronic pancreatitis.

Additional Information

Pancreatin 8000 tablets are enteric-coated to ensure the enzymes are released in the small intestine for optimal absorption. It is important to store the tablets in a cool, dry place away from direct sunlight.

Pharmacological Effects: Pancreatin works by supplementing the digestive enzymes that are lacking in individuals with pancreatic insufficiency. These enzymes help break down fats, proteins, and carbohydrates in the diet, aiding in proper digestion and nutrient absorption.

Clinical Trials: Clinical trials have demonstrated the efficacy of pancreatin in improving symptoms and nutritional status in patients with pancreatic insufficiency. A study published in the “American Journal of Gastroenterology” found that pancreatin therapy led to a significant reduction in malabsorption and improved quality of life in individuals with cystic fibrosis.